Título:
Impacto socioeconómico de pacientes asistidos en la policlínica de EPOC del Hospital Pasteur en 2018
Otros títulos:
Coordinador:
Director:
Compilador:
Autor:
Amaro, Maximiliano
Revello, Analet
Rodríguez, Pablo
Sierra, Giuliana
Tasende, Alejandra
Verde, Daniel
Revello, Analet
Rodríguez, Pablo
Sierra, Giuliana
Tasende, Alejandra
Verde, Daniel
Tutor:
Correa, Selene
de Betolaza, Sofía
de Betolaza, Sofía
Tipo de documento:
Monografía
Editor:
Palabras clave:
EPOC
Severidad
Costos directos
Costos indirectos
COPD
Severity
Direct costs
Indirect costs
Severidad
Costos directos
Costos indirectos
COPD
Severity
Direct costs
Indirect costs
Descriptores:
Año de publicación:
2019
Contenido:
Resumen:
Introducción: La EPOC es una enfermedad respiratoria prevalente con un importante impacto socioeconómico a nivel mundial. Existe escasa bibliografía que cuantifique la repercusión económica de la EPOC en países latinoamericanos.
Objetivos: Estimar el impacto socioeconómico de pacientes con diagnóstico espirométrico de EPOC asistidos en la Policlínica de EPOC del Hospital Pasteur de Montevideo entre el 1º de enero de 2018 y el 31 de diciembre de 2018, determinando los costos directos e indirectos de su atención.
Metodología: Estudio observacional, descriptivo y transversal. Se obtuvieron datos de características demográficas, severidad y costos directos revisando historias clínicas e información sobre costos indirectos mediante una encuesta telefónica.
Resultados: De los 84 pacientes vistos en 2018, 57 tuvieron confirmación espirométrica. Predominó el sexo masculino (64.9%). La edad promedio fue 67.3 ± 11.09 años. 78.8% tenía primaria completa como nivel educativo más avanzado. El tabaquismo estuvo presente en 98.2%. La comorbilidad más prevalente fue el alcoholismo (36.8%), seguido por la hipertensión arterial (35.1%). 45.6% se encontraba en la categoría GOLD B de severidad, seguida por GOLD D (43.8%).
Se analizaron costos directos en 49 pacientes. El total fue USD 190.552,46, correspondiendo 15% a medicamentos (55% oxígenoterapia domiciliaria), 76% exacerbaciones (98% internaciones), 2% estudios paraclínicos y 7% salario médico. Se observó un incremento de costos a medida que aumentaba la categoría de severidad no estadísticamente significativa, probablemente debido al n pequeño. Los costos indirectos se analizaron en 8 pacientes y correspondieron a 14.71% del total de costos.
Conclusiones: La EPOC tiene una importante repercusión socioeconómica, principalmente determinada por los costos de las exacerbaciones. Todos los esfuerzos destinados a disminuirlas e impedir la progresión de la enfermedad van a resultar probablemente en un sustancial beneficio económico.
Introduction: COPD is a prevalent respiratory disease with an important socioeconomic impact worldwide. There is scarce bibliography regarding COPD´s economic impact in Latin American countries. Objectives: To estimate the socioeconomic impact of patients with a COPD spirometric diagnosis assisted at Hospital Pasteur´s COPD clinic in Montevideo between January 1st 2018 and December 31st 2018, determining the direct and indirect costs related to their attention. Methodology: Observational, descriptive and transversal study. Data concerning demographic characteristics, severity and direct costs was obtained revising clinical records, while information concerning indirect costs was obtained through a phone survey. Results: 57 out of the 84 patients seen in 2018 had spirometric confirmation. Male sex prevailed (64.9%). The average age was 67.3 ± 11.09 years. In 78.8% de most advanced education level achieved was primary school. Smoking was present in 98.2%. The most prevalent comorbidity was alcohol abuse (36.8%), followed by arterial hypertension (35.1%). 45.6% belonged to the severity category GOLD B, followed by GOLD D (43.8%). Direct costs were analyzed in 49 patients. The total cost was USD 190.552,46; 15% corresponded to medication (55% home oxygen therapy), 76% exacerbations (98% hospital admissions), 2% diagnostic and follow up studies and 7% doctors´ salary. We observed a tendency to an increase in costs when increasing the severity category which was not statistically significant, probably due to the low n. Indirect costs were analyzed in 8 patients and corresponded to 14.71% of the total cost. Conclusions: COPD has an important socioeconomic impact, determined mostly by the cost of exacerbations. All efforts destined to lower their frequency and stop the disease´s progression will probably result in a substantial economic benefit.
Introduction: COPD is a prevalent respiratory disease with an important socioeconomic impact worldwide. There is scarce bibliography regarding COPD´s economic impact in Latin American countries. Objectives: To estimate the socioeconomic impact of patients with a COPD spirometric diagnosis assisted at Hospital Pasteur´s COPD clinic in Montevideo between January 1st 2018 and December 31st 2018, determining the direct and indirect costs related to their attention. Methodology: Observational, descriptive and transversal study. Data concerning demographic characteristics, severity and direct costs was obtained revising clinical records, while information concerning indirect costs was obtained through a phone survey. Results: 57 out of the 84 patients seen in 2018 had spirometric confirmation. Male sex prevailed (64.9%). The average age was 67.3 ± 11.09 years. In 78.8% de most advanced education level achieved was primary school. Smoking was present in 98.2%. The most prevalent comorbidity was alcohol abuse (36.8%), followed by arterial hypertension (35.1%). 45.6% belonged to the severity category GOLD B, followed by GOLD D (43.8%). Direct costs were analyzed in 49 patients. The total cost was USD 190.552,46; 15% corresponded to medication (55% home oxygen therapy), 76% exacerbations (98% hospital admissions), 2% diagnostic and follow up studies and 7% doctors´ salary. We observed a tendency to an increase in costs when increasing the severity category which was not statistically significant, probably due to the low n. Indirect costs were analyzed in 8 patients and corresponded to 14.71% of the total cost. Conclusions: COPD has an important socioeconomic impact, determined mostly by the cost of exacerbations. All efforts destined to lower their frequency and stop the disease´s progression will probably result in a substantial economic benefit.
Descripción:
Editorial:
Udelar. FM.
EN:
Financiadores:
Citación:
Amaro M, Revello A, Rodríguez P y otros. Impacto socioeconómico de pacientes asistidos en la policlínica de EPOC del Hospital Pasteur en 2018 [en línea]. Monografía de Pre Grado. Montevideo: Udelar. FM, 2019. 31 p.
Citación:
metadata.cc.license.name:
Documento del Gobiberno:
URI:
https://hdl.handle.net/20.500.12008/33852
ISBN:
e-ISBN:
ISSN:
ISMN:
Otros identificadores:
Título Obtenido:
Facultad o Servicio que otorga el Título:
Licencia:
Licencia Creative Commons Atribución - No Comercial - Sin Derivadas (CC - By-NC-ND 4.0)
Cobertura geográfica:
URUGUAY
Cobertura temporal:
metadata.dc.relation.IsVersionOf:
Clasificación:
Es versión de:
Colecciones:
| Ficheros | Descripción | Tamaño | Formato | ||
|---|---|---|---|---|---|
| MCII_2019_G65.pdf | Impacto socioeconómico de pacientes asistidos en la policlínica de EPOC del Hospital Pasteur en 2018 | 875.62 KB | Adobe PDF |